Myriad Genetics Inc (NASDAQ:MYGN)
| 14.55 Delayed Data As of 3:59pm ET |  +0.14 / +0.97%Today’s Change | 9.24 Today|||52-Week Range 48.40 | -46.57% Year-to-Date |
Latest MYGN News | Press Releases
| Could Exact Sciences Be a Millionaire-Maker Stock? May 17 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 14.41 |
| Today’s open | 14.38 |
| Day’s range | 14.20 - 14.60 |
| Volume | 119,731 |
| Average volume (3 months) | 1,116,458 |
| Market cap | $1.1B |
Data as of 3:59pm ET, 05/29/2020
Growth & Valuation
| Earnings growth (last year) | -96.69% |
| Earnings growth (this year) | -112.49% |
| Earnings growth (next 5 years) | -27.41% |
| Revenue growth (last year) | +10.16% |
| P/E ratio | NM |
| Price/Sales | 2.48 |
| Price/Book | 0.99 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VCYTVeracyte Inc | -1.20 | -4.60% |
| CDNACareDx Inc | +0.48 | +1.52% |
| VIVOMeridian Bioscience ... | +1.28 | +9.03% |
| QTNTQuotient Ltd | +0.37 | +4.97% |
Data as of 3:59pm ET, 05/29/2020
Financials
| Next reporting date | August 18, 2020 |
| EPS forecast (this quarter) | -$0.44 |
| Annual revenue (last year) | $851.1M |
| Annual profit (last year) | $4.6M |
| Net profit margin | 0.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
